MEK INHIBITOR-ASSOCIATED RETINOPATHY
Clinical trials for MEK INHIBITOR-ASSOCIATED RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new MEK INHIBITOR-ASSOCIATED RETINOPATHY trials appear
Sign up with your email to follow new studies for MEK INHIBITOR-ASSOCIATED RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Melanoma Drug's eye impact revealed in new study
Knowledge-focused CompletedThis study looked at 14 adults with melanoma who were taking a combination of BRAF and MEK inhibitor drugs. The goal was to understand how these drugs can affect the retina, the light-sensitive part of the eye. Researchers used eye exams and special imaging to track changes over …
Matched conditions: MEK INHIBITOR-ASSOCIATED RETINOPATHY
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Melanoma drug side effects on eyes revealed in new study
Knowledge-focused CompletedThis study examined 30 people with melanoma who were taking BRAF/MEK inhibitor drugs to see how often these drugs cause retinal changes (MEKAR) and what those changes look like. Participants had regular eye exams before, during, and after treatment. The goal was to better underst…
Matched conditions: MEK INHIBITOR-ASSOCIATED RETINOPATHY
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC